###begin article-title 0
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
Cysteine Substitution Mutagenesis and the Effects of Methanethiosulfonate Reagents at P2X2 and P2X4 Receptors Support a Core Common Mode of ATP Action at P2X Receptors*
###end article-title 0
###begin p 1
Present address: School of Chemical Engineering and Analytical Science, University of Manchester.
###end p 1
###begin p 2
###xml 98 111 98 111 <email xmlns:xlink="http://www.w3.org/1999/xlink">rje6@le.ac.uk</email>
 To whom correspondence should be addressed. Tel.: 44-116-229-7059; Fax: 44-116-252-5045; E-mail: rje6@le.ac.uk.
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 413 414 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The agonist binding site of ATP-gated P2X receptors is distinct from other ATP-binding proteins. Mutagenesis on P2X1 receptors of conserved residues in mammalian P2X receptors has established the paradigm that three lysine residues, as well as FT and NFR motifs, play an important role in mediating ATP action. In this study we have determined whether cysteine substitution mutations of equivalent residues in P2X2 and P2X4 receptors have similar effects and if these mutant receptors can be regulated by charged methanethiosulfonate (MTS) compounds. All the mutants (except the P2X2 K69C and K71C that were expressed, but non-functional) showed a significant decrease in ATP potency, with >300-fold decreases for mutants of the conserved asparagine, arginine, and lysine residues close to the end of the extracellular loop. MTS reagents had no effect at the phenylalanine of the FT motif, in contrast, cysteine mutation of the threonine was sensitive to MTS reagents and suggested a role of this residue in ATP action. The lysine-substituted receptors were sensitive to the charge of the MTS reagent consistent with the importance of positive charge at this position for coordination of the negatively charged phosphate of ATP. At the NFR motif the asparagine and arginine residues were sensitive to MTS reagents, whereas the phenylalanine was either unaffected or showed only a small decrease. These results support a common site of ATP action at P2X receptors and suggest that non-conserved residues also play a regulatory role in agonist action.
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 6
###begin p 7
###xml 31 45 31 45 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 188 201 188 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 7
###begin p 8
###xml 248 251 248 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
P2X receptors for ATP comprise a distinct family of ligandgated ion channels, with two transmembrane domains, intracellular amino and carboxyl termini and a large extracellular ligand binding loop. Seven P2X receptor genes have been identified (P2X1-7) and the subunits form functional homo- and heterotrimeric ion channels with a variety of phenotypes (1). ATP is released from neurons, in response to shear stress, as well as from damaged cells. P2X receptors have been shown to be involved in a wide range of physiological roles including blood clotting (2), sensory perception (including pain (3-5), bladder voiding (6), and taste (7)), as well as bone formation (8). As the receptors provide novel drug targets for a range of diseases (9) an understanding of the agonist binding site would be useful for rational drug design. However, it is clear that common ATP binding sequences, e.g. the Walker motif (10), are not present in P2X receptors. In the absence of a crystal structure a site-directed mutagenesis approach has been used to gain insight into amino acids important in mediating the actions of ATP at P2X receptors.
###end p 8
###begin p 9
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 110 116 110 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">3</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 591 592 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1159 1161 1159 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1302 1308 1302 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1437 1439 1437 1439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 1447 1450 1447 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">309</sup>
###xml 1505 1508 1505 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">185</sup>
###xml 1512 1515 1512 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">186</sup>
###xml 1523 1526 1523 1526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">290</sup>
###xml 1530 1533 1530 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">291</sup>
###xml 1537 1540 1537 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">292</sup>
###xml 1588 1589 1588 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1656 1658 1656 1658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 1666 1669 1666 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">291</sup>
###xml 1756 1758 1756 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1828 1829 1828 1829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1837 1838 1837 1838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1850 1852 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1854 1856 1854 1856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1913 1914 1913 1914 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2018 2020 2018 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 2135 2136 2135 2136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2144 2145 2144 2145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2243 2244 2243 2244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 17 22 <span type="species:ncbi:9606">human</span>
We have used the human P2X1 receptor and alanine mutagenesis of conserved residues in the extracellular loop (Fig. 1) to propose a model of the ATP binding site (reviewed in Refs. 11 and 12). Cysteine substitution mutagenesis and charged methanethiosulfonate (MTS)3 compounds have been useful in investigating a variety of ion channels including the pore region (13, 14) as well as residues involved in ATP action/sensitivity at P2X receptors (15, 16). We have used this approach to study the contribution of the 44 amino acids before the second transmembrane domain to ATP action at the P2X1 receptor (16). For example, we have shown that for the mutant K309C, ATP potency and binding of radiolabeled 2-azido-ATP is reduced. The K309C mutant was also accessible to MTS reagents. When positively charged MTSEA ((2-aminoethyl)-methanethiosulfonate hydrobromide) modifies a free cysteine residue it produces a positively charged side chain of similar size to lysine (17). MTSEA application rescued ATP potency at K309C supporting that the charged lysine at this position plays a role in coordinating the binding of the negatively charged phosphate tail of ATP (16). In addition our work with alanine and cysteine mutants has also identified residues that are unlikely to play a major role in ATP action (Fig. 1). Taken together our work has given rise to a model of the ATP binding site with the phosphate tail of ATP bound to residues Lys68 and Lys309, and the aromatic ring sandwiched between residues Phe185-Thr186 and Asn290-Phe291-Arg292. This is supported by a recent study on the P2X1 receptor showing that substituted cysteine mutants of residues Lys68 and Phe291 can form an intersubunit disulfide bond and this is inhibited in the presence of ATP (18). The model is also corroborated by some mutagenesis studies from P2X2 and P2X4 receptors (15, 19). However, an alternative model of ATP action at the P2X4 receptor based on a similarity in predicted structure to the tRNA synthetases has also been suggested (20). In this study to determine whether P2X receptor subunits share a core common mode of ATP action we tested at P2X2 and P2X4 receptors whether cysteine mutagenesis of the residues corresponding to those proposed in the P2X1 receptor model have any effects on ATP potency or the action of MTS reagents.
###end p 9
###begin p 10
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 66 69 66 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 88 111 88 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dictostelium discoideum</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dict</italic>
###xml 9 133 9 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence line-up of the extracellular domain of human P2X<sub>1&#8211;7</sub> receptors and the <italic>Dictostelium discoideum</italic> (<italic>Dict</italic>) P2X receptor (</bold>
###xml 133 135 133 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">37</bold>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37"><bold>37</bold></xref>
###xml 135 137 135 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">).</bold>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 336 350 336 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lowercase gray</italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 522 527 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boxed</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 561 562 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 570 571 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 9 629 9 629 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="11"><bold>Sequence line-up of the extracellular domain of human P2X<sub>1&#8211;7</sub> receptors and the <italic>Dictostelium discoideum</italic> (<italic>Dict</italic>) P2X receptor (</bold><xref ref-type="bibr" rid="ref37"><bold>37</bold></xref><bold>).</bold> Residues conserved in at least 5 of the human P2X receptors are shown in <italic>red</italic>. Alanine or cysteine mutants of the P2X<sub>1</sub> receptor that have no or less than a 10-fold change in ATP potency are shown in <italic>lowercase gray</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). P2X<sub>1</sub> receptor mutants with a greater than 10-fold decrease in ATP potency are shown in <italic>blue</italic>. Residues that have been suggested to be important in ATP action are <italic>boxed</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). Cysteine mutants of P2X<sub>2</sub> and P2X<sub>4</sub> receptors characterized in this paper are shown in <italic>green</italic>.</p>
###xml 9 629 9 629 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="11"><bold>Sequence line-up of the extracellular domain of human P2X<sub>1&#8211;7</sub> receptors and the <italic>Dictostelium discoideum</italic> (<italic>Dict</italic>) P2X receptor (</bold><xref ref-type="bibr" rid="ref37"><bold>37</bold></xref><bold>).</bold> Residues conserved in at least 5 of the human P2X receptors are shown in <italic>red</italic>. Alanine or cysteine mutants of the P2X<sub>1</sub> receptor that have no or less than a 10-fold change in ATP potency are shown in <italic>lowercase gray</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). P2X<sub>1</sub> receptor mutants with a greater than 10-fold decrease in ATP potency are shown in <italic>blue</italic>. Residues that have been suggested to be important in ATP action are <italic>boxed</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). Cysteine mutants of P2X<sub>2</sub> and P2X<sub>4</sub> receptors characterized in this paper are shown in <italic>green</italic>.</p></caption>
###xml 629 629 629 629 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800001"/>
###xml 0 629 0 629 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="11"><bold>Sequence line-up of the extracellular domain of human P2X<sub>1&#8211;7</sub> receptors and the <italic>Dictostelium discoideum</italic> (<italic>Dict</italic>) P2X receptor (</bold><xref ref-type="bibr" rid="ref37"><bold>37</bold></xref><bold>).</bold> Residues conserved in at least 5 of the human P2X receptors are shown in <italic>red</italic>. Alanine or cysteine mutants of the P2X<sub>1</sub> receptor that have no or less than a 10-fold change in ATP potency are shown in <italic>lowercase gray</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). P2X<sub>1</sub> receptor mutants with a greater than 10-fold decrease in ATP potency are shown in <italic>blue</italic>. Residues that have been suggested to be important in ATP action are <italic>boxed</italic> (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). Cysteine mutants of P2X<sub>2</sub> and P2X<sub>4</sub> receptors characterized in this paper are shown in <italic>green</italic>.</p></caption><graphic xlink:href="zbc0320843800001"/></fig>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
FIGURE 1.Sequence line-up of the extracellular domain of human P2X1-7 receptors and the Dictostelium discoideum (Dict) P2X receptor (37). Residues conserved in at least 5 of the human P2X receptors are shown in red. Alanine or cysteine mutants of the P2X1 receptor that have no or less than a 10-fold change in ATP potency are shown in lowercase gray (12, 16). P2X1 receptor mutants with a greater than 10-fold decrease in ATP potency are shown in blue. Residues that have been suggested to be important in ATP action are boxed (12, 16). Cysteine mutants of P2X2 and P2X4 receptors characterized in this paper are shown in green.
###end p 10
###begin p 11
###xml 57 60 57 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 79 102 79 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dictostelium discoideum</italic>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dict</italic>
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence line-up of the extracellular domain of human P2X<sub>1&#8211;7</sub> receptors and the <italic>Dictostelium discoideum</italic> (<italic>Dict</italic>) P2X receptor (</bold>
###xml 124 126 124 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">37</bold>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37"><bold>37</bold></xref>
###xml 126 128 126 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">).</bold>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 327 341 327 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lowercase gray</italic>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 355 356 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">boxed</italic>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 552 553 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 562 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
Sequence line-up of the extracellular domain of human P2X1-7 receptors and the Dictostelium discoideum (Dict) P2X receptor (37). Residues conserved in at least 5 of the human P2X receptors are shown in red. Alanine or cysteine mutants of the P2X1 receptor that have no or less than a 10-fold change in ATP potency are shown in lowercase gray (12, 16). P2X1 receptor mutants with a greater than 10-fold decrease in ATP potency are shown in blue. Residues that have been suggested to be important in ATP action are boxed (12, 16). Cysteine mutants of P2X2 and P2X4 receptors characterized in this paper are shown in green.
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin p 13
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Site-directed Mutagenesis</italic>
###xml 155 156 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 177 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 224 225 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 337 339 328 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 368 369 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 422 423 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">4</xref>
###xml 439 440 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 587 589 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 667 668 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 676 677 665 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 169 172 <span type="species:ncbi:10116">rat</span>
###xml 215 220 <span type="species:ncbi:9606">Human</span>
###xml 432 435 <span type="species:ncbi:10116">rat</span>
Site-directed Mutagenesis-Cysteine point mutations for residues were introduced via the QuikChangetrade mark mutagenesis kit (Stratagene) using a human P2X2 receptor or rat P2X4-myc (Y378A) plasmid as the template. Human P2X2 receptor plasmid (gift of Dr. Andrew Powell, GlaxoSmithKline, United Kingdom) contained the sequence of the P2X2a isoform (Q9UBL9) with the NH2-terminal variant MAAAQPKYPAGATA --> MV as described.4 For the rat P2X4-myc (gift of Dr. Francois Rassendren, CNRS, Montpellier, France), the mutant Y378A was created and used as the template for more stable currents (21). Production of the correct mutations and absence of coding errors in the P2X2 and P2X4 mutant constructs was verified by DNA sequencing (Automated ABI Sequencing Service, University of Leicester).
###end p 13
###begin p 14
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Expression in Xenopus laevis Oocytes</italic>
###xml 182 184 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 218 227 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X. laevis</italic>
###xml 400 401 385 386 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 411 412 396 397 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 423 424 408 409 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 429 430 414 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 435 436 420 421 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 441 442 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 447 448 432 433 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 469 470 454 455 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 14 28 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 218 227 <span type="species:ncbi:8355">X. laevis</span>
Expression in Xenopus laevis Oocytes-Wild type and mutant constructs were transcribed to produce sense strand cRNA (mMessage mMachinetrade mark, Ambion, TX) as described previously (22). Manually defoliculated stage V X. laevis oocytes were injected with 50 nl (50 ng) of cRNA using an Inject+Matic microinjector (J. Alejandro Gaby, Geneva, Switzerland) and stored at 18 degreesC in ND96 buffer (96 mm NaCl, 2 mm KCl, 1.8 mm CaCl2, 1 mm MgCl2, 5 mm sodium pyruvate, 5 mm HEPES, pH 7.6). Media was changed daily prior to recording 3-7 days later.
###end p 14
###begin p 15
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Electrophysiological Recordings</italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 436 437 436 437 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 442 443 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 454 455 454 455 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 571 572 570 571 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 580 581 579 580 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 759 760 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 765 766 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 767 768 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H</sup>
###xml 771 772 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 776 777 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 778 779 777 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H</sup>
###xml 785 787 784 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 788 789 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H</sup>
###xml 798 799 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 813 814 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 841 842 840 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 868 869 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 897 899 896 898 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 972 974 971 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 986 988 985 987 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 998 1000 997 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1104 1105 1103 1104 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1132 1134 1131 1133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1265 1267 1264 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
Electrophysiological Recordings-Two-electrode voltage clamp recordings (at a holding potential of -60 mV) were carried out on cRNA-injected oocytes using a GeneClamp 500B amplifier with a Digidata 1322 analog to digital converter and pClamp 8.2 acquisition software (Axon Instruments) as previously described (22). Native oocyte calcium-activated chloride currents in response to P2X receptor stimulation were reduced by replacing 1.8 mm CaCl2 with 1.8 mm BaCl2 in the ND96 bath solution. ATP (magnesium salt, Sigma) was applied via a U-tube perfusion system. ATP (0.1 mum to 10 mm) was applied at 5-min intervals, using this regime reproducible ATP-evoked responses were recorded. Individual concentration-response curves were fitted with the Hill equation: Y = [(X)H x M]/[(X)H + (EC50)H], where Y is response, X is agonist concentration, H is the Hill coefficient, M is maximum response, and EC50 is the concentration of agonist evoking 50% of the maximum response. pEC50 is the -log10 of the EC50 value. Mutants that had considerably shifted ATP potency were tested with ATP concentrations up to 10 mm. For the calculation of EC50 values individual concentration-response curves were generated for each experiment and statistical analysis carried out on the pEC50 data generated. In the figures, concentration-response curves are fitted to the mean normalized data.
###end p 15
###begin p 16
###xml 0 65 0 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of the Effects of Methanethiosulfonate Compounds</italic>
###xml 176 178 164 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 516 518 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 520 522 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 542 543 530 531 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 738 739 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Characterization of the Effects of Methanethiosulfonate Compounds-To study the effect of MTS compounds on ATP activation at wild type and cysteine mutants, ATP (approximatelyEC50 concentration) was applied and either MTSEA or sodium (2-sulfonatoethyl)methanethiosulfonate (MTSES) (Toronto Research Chemicals, Toronto, Canada) were bath-perfused (for at least 5 min; the recovery time required between application to see reproducible responses) prior to coapplication with ATP via the U-tube as described previously (15, 16). MTS reagents (1 mm) were made in ND96 solution immediately prior to use. MTS reagents were applied for 10 min with the maximal, or near maximal response seen after 5 min. The effects of the MTS reagents on the P2X2 receptor mutants were the same following washout of the compounds showing that they irreversibly modified the receptors.
###end p 16
###begin p 17
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 432 433 432 433 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 580 581 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 666 668 666 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 772 773 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1208 1209 1208 1209 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1613 1614 1613 1614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1686 1688 1686 1688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
The effects of the MTS compounds on the mutant P2X4 receptors were reversible following a 5-10 min washout. The P2X4 receptor has been shown to be subject to extensive constitutive and agonist induced trafficking (23) even for the Y378A mutant used in this study (21, 24). To determine whether longer incubations could be used to irreversibly modify P2X4 mutant receptors we treated the oocytes for 3 h in the presence of MTSES (1 mm) and 3.2 units/ml of apyrase to break down any endogenous ATP, or just apyrase. This longer incubation was aimed to modify more of the pool of P2X4 receptors. This was followed by washing and subsequent testing of responses to an EC50 concentration of ATP (in the absence of MTSES). This treatment had no effect on the amplitude of WT P2X4 receptor currents, however, reductions of the mutants were equivalent to those where MTSES was present during the recordings demonstrating that any changes in properties for the mutant receptors result from irreversible modification of introduced cysteine residues and that cysteine residues were available in the resting un-liganded state of the receptor. MTS reagents have a reasonably short half-life and this suggests that the 1 mm concentration used is supramaximal and there was still sufficient reagent present during the 3-h incubation to irreversibly modify the receptors. These results suggest that the reversal of MTS effects following washout of short applications is likely to result from trafficking of un-modified receptors to the cell surface and longer incubations are required to irreversibly modify the whole pool of P2X4 mutant receptors. We have therefore presented data for effects on an EC50 concentration of ATP during the presence of the MTS reagents as this allows us to analyze data from the same oocyte before and during application of the reagents.
###end p 17
###begin p 18
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 145 146 145 146 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 384 385 384 385 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
The effects of MTS reagents on the concentration responses to ATP for P2X2 receptors were investigated following washout of MTSEA (applied at 1 mm for 10 min in the absence of agonist), there was no effect on WT responses. For P2X4 receptors the effects of MTSEA on concentration responses were investigated by application of ATP following incubating the oocytes for 1 h in MTSEA (1 mm) and washout of MTSEA. ATP concentrations were applied via the U-tube with ND96 bathing solution (no MTS reagents present).
###end p 18
###begin p 19
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blotting</italic>
###xml 298 299 298 299 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 310 311 310 311 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1026 1028 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1252 1253 1244 1245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1260 1261 1252 1253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Western Blotting-Expression levels of wild type and mutant receptors were estimated by Western blot analysis of total cellular protein and cell surface proteins. Total cellular protein samples were prepared from oocytes injected with wild type or mutant receptor cRNA homogenized in buffer H (100 mm NaCl, 20 mm Tris-Cl, pH 7.4, 1% Triton X-100, and 10 mul/ml protease inhibitor mixture) at 20 mul/oocyte. Sulfo-NHS-LC-Biotin (Pierce) labels cell surface proteins by reacting with primary amines and was used to estimate the level of wild type or mutant receptor trafficked to the cell surface membrane. Sulfo-NHS-LC-biotin is impermeable to the cell membrane and can only biotinylate proteins available at the cell surface. Oocytes injected with wild type or mutant receptor cRNA were treated with sulfo-NHS-LC-biotin (0.5 mg/ml) in ND96 for 30 min and washed with ND96. Oocytes were homogenized in buffer H, and the spin-cleared supernatant was mixed with streptavidin-agarose beads (Sigma) treated as described previously (25). All samples were mixed with SDS sample buffer and heated to 95 degreesC for 5 min prior to loading. Samples were run on a 10% SDS-PAGE gel, transferred to nitrocellulose, and screened for immunoreactivity for the anti-P2X2 or P2X4 antibody (1:500) (Alomone, Israel).
###end p 19
###begin p 20
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis</italic>
###xml 456 457 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 464 465 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Analysis-All data are shown as mean +/- S.E. Significant differences between WT and mutant maximum current amplitudes, agonist potency, and MTS reagent modification were calculated by one-way analysis of variance followed by Dunnett's test for comparisons of individual mutants against control using the GraphPad Prism package. Differences in mutant concentration response curves for individual mutants, on treatment with MTSEA, were tested with Student's t test. n corresponds to the number of oocytes tested for electrophysiological data.
###end p 20
###begin title 21
RESULTS
###end title 21
###begin p 22
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 62 0 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Cysteine Mutants on ATP Responses at P2X<sub>2</sub> Receptors</italic>
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 175 176 162 163 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 178 184 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 189 196 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 253 255 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 257 259 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 261 263 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 403 409 390 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 411 418 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 491 492 478 479 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 637 638 612 613 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 656 658 631 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 666 667 641 642 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 704 705 679 680 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 759 761 734 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 789 790 764 765 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 837 838 812 813 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 936 937 911 912 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1467 1468 1430 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1479 1481 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Effects of Cysteine Mutants on ATP Responses at P2X2 Receptors-At WT human P2X2 receptors ATP evoked concentration-dependent inward currents with an EC50 of approximately13 mum (Fig. 2 and Table 1) similar to that reported previously for this receptor (14, 15, 26). Robust currents were also recorded for F183C, T184C, and F289C mutants, however, they showed a modest 4-10-fold decrease in ATP potency (Fig. 2, Table 1). The peak amplitude of currents to a maximal concentration of ATP (10 mm) were reduced by approximately90% for the mutant R290C and for this receptor the amplitude of responses continued to increase between 3 and 10 mm indicating the EC50 is >3 mm ATP. At mutants N288C and K307C 10 mm ATP evoked very small currents suggesting that the EC50 for these receptors is >3 mm. No currents were recorded in response to 10 mm ATP for mutants K69C and K71C. Analysis of the expression of both total and surface levels of P2X2 WT and mutant receptors with reduced peak current amplitudes showed that there was at most an approximately50% reduction in surface expression (K307C), predicting a halving in peak current amplitude, however, there was a >97% reduction in amplitudes for K69C, K71C, and N288C. This indicates that any reductions in current amplitude compared with WT were predominantly due to an effect on channel properties and not trafficking to the cell surface. Overall these results are consistent with those from similar mutants for the P2X1 receptor (12).
###end p 22
###begin p 23
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 7 71 7 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of the effects of cysteine substitution on P2X<sub>2</sub> and P2X<sub>4</sub></bold>
###xml 7 71 7 71 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><bold>Summary of the effects of cysteine substitution on P2X<sub>2</sub> and P2X<sub>4</sub></bold></p>
###xml 184 185 183 184 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 193 194 192 193 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 200 202 199 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 257 259 256 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 279 281 278 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 71 465 71 464 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Peak current values taken on 1st application of a maximal concentration of ATP (a saturating concentration 300 &#956;<sc>m</sc> to 10 m<sc>m</sc>). pEC<sub>50</sub> values shown as calculated from experimental data. pEC<sub>50</sub> is &#8211;log10 of the EC<sub>50</sub>. MTS data (effect of ATP applied in the presence of MTS reagent) calculated as a percentage of the control (effect of ATP applied in the absence of MTS reagent) which was set as 100%.</p>
###xml 7 465 7 464 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24"><bold>Summary of the effects of cysteine substitution on P2X<sub>2</sub> and P2X<sub>4</sub></bold></p><p textid="25">Peak current values taken on 1st application of a maximal concentration of ATP (a saturating concentration 300 &#956;<sc>m</sc> to 10 m<sc>m</sc>). pEC<sub>50</sub> values shown as calculated from experimental data. pEC<sub>50</sub> is &#8211;log10 of the EC<sub>50</sub>. MTS data (effect of ATP applied in the presence of MTS reagent) calculated as a percentage of the control (effect of ATP applied in the absence of MTS reagent) which was set as 100%.</p></caption>
###xml 465 465 464 464 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 465 473 464 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink">nA (max)</bold>
###xml 465 473 464 472 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>nA (max)</bold></th>
###xml 475 477 474 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 473 477 472 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EC<sub>50</sub></bold>
###xml 473 477 472 476 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>EC<sub>50</sub></bold></th>
###xml 477 482 476 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink">pEC50</bold>
###xml 477 482 476 481 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>pEC50</bold></th>
###xml 482 487 481 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MTSEA</bold>
###xml 482 487 481 486 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>MTSEA</bold></th>
###xml 487 492 486 491 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MTSES</bold>
###xml 487 492 486 491 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>MTSES</bold></th>
###xml 465 492 464 491 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>nA (max)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EC<sub>50</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pEC50</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSEA</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSES</bold></th></tr>
###xml 465 492 464 491 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>nA (max)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EC<sub>50</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pEC50</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSEA</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSES</bold></th></tr></thead>
###xml 492 502 491 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human P2X2</bold>
###xml 492 502 491 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>Human P2X2</bold></td>
###xml 502 502 501 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 502 502 501 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 502 502 501 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 502 502 501 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 502 502 501 501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 492 502 491 501 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><bold>Human P2X2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 502 510 501 509 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td>
###xml 510 524 509 521 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4465 &#177; 477 </td>
###xml 530 531 526 527 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 524 531 521 527 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td>
###xml 531 545 527 539 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.1 </td>
###xml 545 557 539 549 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 127 &#177; 2% </td>
###xml 557 569 549 559 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 101 &#177; 3% </td>
###xml 502 569 501 559 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 4465 &#177; 477 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 127 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 101 &#177; 3% </td></tr>
###xml 569 579 559 569 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td>
###xml 582 583 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 582 583 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref>
###xml 579 583 569 573 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td>
###xml 583 587 573 577 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF </td>
###xml 587 591 577 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF </td>
###xml 591 602 581 592 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> No effect </td>
###xml 602 613 592 603 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> No effect </td>
###xml 569 613 559 603 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr>
###xml 613 623 603 613 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K71C </td>
###xml 623 627 613 617 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF </td>
###xml 627 631 617 621 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF </td>
###xml 631 635 621 625 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> NF </td>
###xml 635 646 625 636 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> No effect </td>
###xml 646 657 636 647 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> No effect </td>
###xml 613 657 603 647 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K71C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr>
###xml 657 668 647 658 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F183C </td>
###xml 668 683 658 671 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4661 &#177; 1209 </td>
###xml 689 690 676 677 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 683 690 671 677 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 40 &#956;<sc>m</sc></td>
###xml 703 704 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 703 704 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref>
###xml 690 704 677 689 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4.40 &#177; 0.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
###xml 704 716 689 699 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 128 &#177; 2% </td>
###xml 716 727 699 708 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 96 &#177; 1% </td>
###xml 657 727 647 708 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F183C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4661 &#177; 1209 </td><td colspan="1" rowspan="1" align="center" valign="top"> 40 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.40 &#177; 0.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 128 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 96 &#177; 1% </td></tr>
###xml 727 738 708 719 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T184C </td>
###xml 738 753 719 732 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4515 &#177; 1402 </td>
###xml 760 761 738 739 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 753 761 732 739 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 117 &#956;<sc>m</sc></td>
###xml 774 775 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 774 775 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 761 775 739 751 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 3.93 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 787 788 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 787 788 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref>
###xml 775 788 751 762 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 195 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
###xml 798 799 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 798 799 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 788 799 762 771 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 20 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 727 799 708 771 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T184C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4515 &#177; 1402 </td><td colspan="1" rowspan="1" align="center" valign="top"> 117 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.93 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 195 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 20 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 799 810 771 782 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N288C </td>
###xml 819 820 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 819 820 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref>
###xml 810 820 782 790 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 13 &#177; 2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
###xml 825 826 795 796 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 820 826 790 796 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td>
###xml 826 833 796 803 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td>
###xml 843 844 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 843 844 811 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref>
###xml 833 844 803 812 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 22 &#177; 5%<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
###xml 854 855 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 854 855 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 844 855 812 821 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 21 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 799 855 771 821 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N288C </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#177; 2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 22 &#177; 5%<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 21 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 855 866 821 832 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F289C </td>
###xml 866 880 832 844 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2279 &#177; 583 </td>
###xml 886 887 849 850 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 880 887 844 850 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 64 &#956;<sc>m</sc></td>
###xml 900 901 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 900 901 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 887 901 850 862 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4.19 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 901 914 862 873 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 123 &#177; 11% </td>
###xml 925 926 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 925 926 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref>
###xml 914 926 873 883 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 78 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
###xml 855 926 821 883 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F289C </td><td colspan="1" rowspan="1" align="center" valign="top"> 2279 &#177; 583 </td><td colspan="1" rowspan="1" align="center" valign="top"> 64 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.19 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 123 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 78 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td></tr>
###xml 926 937 883 894 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;R290C </td>
###xml 948 949 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 948 949 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref>
###xml 937 949 894 904 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 525 &#177; 70<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
###xml 954 955 909 910 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 949 955 904 910 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td>
###xml 955 962 910 917 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td>
###xml 976 977 929 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 976 977 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 962 977 917 930 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1237 &#177; 249%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 987 988 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 987 988 938 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 977 988 930 939 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 27 &#177; 7%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 926 988 883 939 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;R290C </td><td colspan="1" rowspan="1" align="center" valign="top"> 525 &#177; 70<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1237 &#177; 249%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 27 &#177; 7%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 988 999 939 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K307C </td>
###xml 1009 1010 958 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1009 1010 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 999 1010 950 959 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 49 &#177; 20<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1015 1016 964 965 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1010 1016 959 965 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td>
###xml 1016 1023 965 972 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td>
###xml 1039 1040 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1039 1040 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1023 1040 972 987 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 27500 &#177; 6660%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1050 1051 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1050 1051 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1040 1051 987 996 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 988 1051 939 996 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K307C </td><td colspan="1" rowspan="1" align="center" valign="top"> 49 &#177; 20<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 27500 &#177; 6660%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 492 1051 491 996 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Human P2X2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 4465 &#177; 477 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 127 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 101 &#177; 3% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K71C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F183C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4661 &#177; 1209 </td><td colspan="1" rowspan="1" align="center" valign="top"> 40 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.40 &#177; 0.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 128 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 96 &#177; 1% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T184C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4515 &#177; 1402 </td><td colspan="1" rowspan="1" align="center" valign="top"> 117 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.93 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 195 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 20 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N288C </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#177; 2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 22 &#177; 5%<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 21 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F289C </td><td colspan="1" rowspan="1" align="center" valign="top"> 2279 &#177; 583 </td><td colspan="1" rowspan="1" align="center" valign="top"> 64 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.19 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 123 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 78 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;R290C </td><td colspan="1" rowspan="1" align="center" valign="top"> 525 &#177; 70<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1237 &#177; 249%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 27 &#177; 7%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K307C </td><td colspan="1" rowspan="1" align="center" valign="top"> 49 &#177; 20<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 27500 &#177; 6660%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody>
###xml 1051 1071 996 1016 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rat P2X4-myc (Y378A)</bold>
###xml 1051 1071 996 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>Rat P2X4-myc (Y378A)</bold></td>
###xml 1071 1071 1016 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1071 1071 1016 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1071 1071 1016 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1071 1071 1016 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1071 1071 1016 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1051 1071 996 1016 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><bold>Rat P2X4-myc (Y378A)</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 1071 1079 1016 1024 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td>
###xml 1079 1093 1024 1036 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2513 &#177; 187 </td>
###xml 1099 1100 1041 1042 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1093 1100 1036 1042 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td>
###xml 1100 1115 1042 1055 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.02 </td>
###xml 1115 1128 1055 1066 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 103 &#177; 11% </td>
###xml 1128 1140 1066 1076 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 108 &#177; 6% </td>
###xml 1071 1140 1016 1076 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 2513 &#177; 187 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 103 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 108 &#177; 6% </td></tr>
###xml 1140 1150 1076 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K67C </td>
###xml 1160 1161 1094 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 1160 1161 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref>
###xml 1150 1161 1086 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 66 &#177; 21<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
###xml 1164 1165 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1164 1165 1098 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref>
###xml 1161 1165 1095 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> ND<xref ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref></td>
###xml 1165 1169 1099 1103 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> ND </td>
###xml 1183 1184 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1183 1184 1115 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1169 1184 1103 1116 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2076 &#177; 485%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1194 1195 1124 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1194 1195 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1184 1195 1116 1125 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 4%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1140 1195 1076 1125 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K67C </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 &#177; 21<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND<xref ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND </td><td colspan="1" rowspan="1" align="center" valign="top"> 2076 &#177; 485%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 4%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 1195 1205 1125 1135 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td>
###xml 1205 1218 1135 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 821 &#177; 146 </td>
###xml 1223 1224 1151 1152 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1218 1224 1146 1152 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td>
###xml 1224 1231 1152 1159 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td>
###xml 1243 1244 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1243 1244 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1231 1244 1159 1170 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 350 &#177; 50%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1253 1254 1177 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1253 1254 1177 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1244 1254 1170 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1195 1254 1125 1178 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> 821 &#177; 146 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 350 &#177; 50%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 1 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 1254 1265 1178 1189 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F185C </td>
###xml 1265 1278 1189 1200 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 587 &#177; 224 </td>
###xml 1285 1286 1206 1207 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1278 1286 1200 1207 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 265 &#956;<sc>m</sc></td>
###xml 1300 1301 1219 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1300 1301 1219 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1286 1301 1207 1220 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 3.58 &#177; 0.07<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1301 1312 1220 1229 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 93 &#177; 7% </td>
###xml 1312 1323 1229 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 95 &#177; 2% </td>
###xml 1254 1323 1178 1238 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F185C </td><td colspan="1" rowspan="1" align="center" valign="top"> 587 &#177; 224 </td><td colspan="1" rowspan="1" align="center" valign="top"> 265 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.58 &#177; 0.07<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 93 &#177; 7% </td><td colspan="1" rowspan="1" align="center" valign="top"> 95 &#177; 2% </td></tr>
###xml 1323 1334 1238 1249 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T186C </td>
###xml 1334 1348 1249 1261 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1706 &#177; 425 </td>
###xml 1355 1356 1267 1268 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1348 1356 1261 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 650 &#956;<sc>m</sc></td>
###xml 1370 1371 1280 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1370 1371 1280 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1356 1371 1268 1281 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 3.19 &#177; 0.04<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1381 1382 1289 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 1381 1382 1289 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref>
###xml 1371 1382 1281 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 35 &#177; 6%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td>
###xml 1391 1392 1297 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1391 1392 1297 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1382 1392 1290 1298 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 8 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1323 1392 1238 1298 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T186C </td><td colspan="1" rowspan="1" align="center" valign="top"> 1706 &#177; 425 </td><td colspan="1" rowspan="1" align="center" valign="top"> 650 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.19 &#177; 0.04<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 35 &#177; 6%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 8 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 1392 1403 1298 1309 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N293C </td>
###xml 1403 1416 1309 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 521 &#177; 164 </td>
###xml 1421 1422 1325 1326 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1416 1422 1320 1326 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td>
###xml 1422 1429 1326 1333 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td>
###xml 1438 1439 1340 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1438 1439 1340 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1429 1439 1333 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 6 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1447 1448 1347 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 1447 1448 1347 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref>
###xml 1439 1448 1341 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2 &#177; 1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td>
###xml 1392 1448 1298 1348 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N293C </td><td colspan="1" rowspan="1" align="center" valign="top"> 521 &#177; 164 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2 &#177; 1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr>
###xml 1051 1448 996 1348 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Rat P2X4-myc (Y378A)</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 2513 &#177; 187 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 103 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 108 &#177; 6% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K67C </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 &#177; 21<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND<xref ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND </td><td colspan="1" rowspan="1" align="center" valign="top"> 2076 &#177; 485%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 4%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> 821 &#177; 146 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 350 &#177; 50%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 1 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F185C </td><td colspan="1" rowspan="1" align="center" valign="top"> 587 &#177; 224 </td><td colspan="1" rowspan="1" align="center" valign="top"> 265 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.58 &#177; 0.07<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 93 &#177; 7% </td><td colspan="1" rowspan="1" align="center" valign="top"> 95 &#177; 2% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T186C </td><td colspan="1" rowspan="1" align="center" valign="top"> 1706 &#177; 425 </td><td colspan="1" rowspan="1" align="center" valign="top"> 650 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.19 &#177; 0.04<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 35 &#177; 6%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 8 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N293C </td><td colspan="1" rowspan="1" align="center" valign="top"> 521 &#177; 164 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2 &#177; 1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody>
###xml 465 1448 464 1348 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>nA (max)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EC<sub>50</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pEC50</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSEA</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSES</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Human P2X2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 4465 &#177; 477 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 127 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 101 &#177; 3% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K71C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F183C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4661 &#177; 1209 </td><td colspan="1" rowspan="1" align="center" valign="top"> 40 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.40 &#177; 0.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 128 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 96 &#177; 1% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T184C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4515 &#177; 1402 </td><td colspan="1" rowspan="1" align="center" valign="top"> 117 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.93 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 195 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 20 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N288C </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#177; 2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 22 &#177; 5%<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 21 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F289C </td><td colspan="1" rowspan="1" align="center" valign="top"> 2279 &#177; 583 </td><td colspan="1" rowspan="1" align="center" valign="top"> 64 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.19 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 123 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 78 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;R290C </td><td colspan="1" rowspan="1" align="center" valign="top"> 525 &#177; 70<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1237 &#177; 249%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 27 &#177; 7%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K307C </td><td colspan="1" rowspan="1" align="center" valign="top"> 49 &#177; 20<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 27500 &#177; 6660%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Rat P2X4-myc (Y378A)</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 2513 &#177; 187 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 103 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 108 &#177; 6% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K67C </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 &#177; 21<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND<xref ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND </td><td colspan="1" rowspan="1" align="center" valign="top"> 2076 &#177; 485%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 4%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> 821 &#177; 146 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 350 &#177; 50%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 1 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F185C </td><td colspan="1" rowspan="1" align="center" valign="top"> 587 &#177; 224 </td><td colspan="1" rowspan="1" align="center" valign="top"> 265 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.58 &#177; 0.07<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 93 &#177; 7% </td><td colspan="1" rowspan="1" align="center" valign="top"> 95 &#177; 2% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T186C </td><td colspan="1" rowspan="1" align="center" valign="top"> 1706 &#177; 425 </td><td colspan="1" rowspan="1" align="center" valign="top"> 650 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.19 &#177; 0.04<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 35 &#177; 6%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 8 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N293C </td><td colspan="1" rowspan="1" align="center" valign="top"> 521 &#177; 164 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2 &#177; 1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody></table>
###xml 1448 1449 1348 1349 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 1449 1467 1349 1367 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">NF, nonfunctional.</p>
###xml 1448 1467 1348 1367 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn1"><label>a</label><p textid="26">NF, nonfunctional.</p></fn>
###xml 1467 1468 1367 1368 <label xmlns:xlink="http://www.w3.org/1999/xlink">b</label>
###xml 1468 1469 1368 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1478 1479 1378 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1468 1487 1368 1387 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><italic>p</italic> &lt; 0.01, <italic>n</italic> = 3-18.</p>
###xml 1467 1487 1367 1387 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn2"><label>b</label><p textid="27"><italic>p</italic> &lt; 0.01, <italic>n</italic> = 3-18.</p></fn>
###xml 1487 1488 1387 1388 <label xmlns:xlink="http://www.w3.org/1999/xlink">c</label>
###xml 1488 1489 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1499 1500 1399 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1488 1508 1388 1408 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><italic>p</italic> &lt; 0.001, <italic>n</italic> = 3-18.</p>
###xml 1487 1508 1387 1408 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn3"><label>c</label><p textid="28"><italic>p</italic> &lt; 0.001, <italic>n</italic> = 3-18.</p></fn>
###xml 1508 1509 1408 1409 <label xmlns:xlink="http://www.w3.org/1999/xlink">d</label>
###xml 1509 1510 1409 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1519 1520 1419 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1509 1528 1409 1428 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><italic>p</italic> &lt; 0.05, <italic>n</italic> = 3-18.</p>
###xml 1508 1528 1408 1428 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn4"><label>d</label><p textid="29"><italic>p</italic> &lt; 0.05, <italic>n</italic> = 3-18.</p></fn>
###xml 1528 1529 1428 1429 <label xmlns:xlink="http://www.w3.org/1999/xlink">e</label>
###xml 1529 1548 1429 1448 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">ND, not determined.</p>
###xml 1528 1548 1428 1448 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn5"><label>e</label><p textid="30">ND, not determined.</p></fn>
###xml 1448 1548 1348 1448 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn1"><label>a</label><p textid="26">NF, nonfunctional.</p></fn><fn id="tblfn2"><label>b</label><p textid="27"><italic>p</italic> &lt; 0.01, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn3"><label>c</label><p textid="28"><italic>p</italic> &lt; 0.001, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn4"><label>d</label><p textid="29"><italic>p</italic> &lt; 0.05, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn5"><label>e</label><p textid="30">ND, not determined.</p></fn></table-wrap-foot>
###xml 0 1548 0 1448 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="24"><bold>Summary of the effects of cysteine substitution on P2X<sub>2</sub> and P2X<sub>4</sub></bold></p><p textid="25">Peak current values taken on 1st application of a maximal concentration of ATP (a saturating concentration 300 &#956;<sc>m</sc> to 10 m<sc>m</sc>). pEC<sub>50</sub> values shown as calculated from experimental data. pEC<sub>50</sub> is &#8211;log10 of the EC<sub>50</sub>. MTS data (effect of ATP applied in the presence of MTS reagent) calculated as a percentage of the control (effect of ATP applied in the absence of MTS reagent) which was set as 100%.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>nA (max)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>EC<sub>50</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>pEC50</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSEA</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>MTSES</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Human P2X2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 4465 &#177; 477 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.1 </td><td colspan="1" rowspan="1" align="center" valign="top"> 127 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 101 &#177; 3% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF<xref ref-type="table-fn" rid="tblfn1"><italic>a</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K71C </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> NF </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td><td colspan="1" rowspan="1" align="center" valign="top"> No effect </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F183C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4661 &#177; 1209 </td><td colspan="1" rowspan="1" align="center" valign="top"> 40 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.40 &#177; 0.1<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 128 &#177; 2% </td><td colspan="1" rowspan="1" align="center" valign="top"> 96 &#177; 1% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T184C </td><td colspan="1" rowspan="1" align="center" valign="top"> 4515 &#177; 1402 </td><td colspan="1" rowspan="1" align="center" valign="top"> 117 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.93 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 195 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 20 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N288C </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#177; 2<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 22 &#177; 5%<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 21 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F289C </td><td colspan="1" rowspan="1" align="center" valign="top"> 2279 &#177; 583 </td><td colspan="1" rowspan="1" align="center" valign="top"> 64 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.19 &#177; 0.1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 123 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 78 &#177; 11%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;R290C </td><td colspan="1" rowspan="1" align="center" valign="top"> 525 &#177; 70<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1237 &#177; 249%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 27 &#177; 7%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K307C </td><td colspan="1" rowspan="1" align="center" valign="top"> 49 &#177; 20<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 27500 &#177; 6660%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Rat P2X4-myc (Y378A)</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;WT </td><td colspan="1" rowspan="1" align="center" valign="top"> 2513 &#177; 187 </td><td colspan="1" rowspan="1" align="center" valign="top"> 13 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 4.89 &#177; 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 103 &#177; 11% </td><td colspan="1" rowspan="1" align="center" valign="top"> 108 &#177; 6% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K67C </td><td colspan="1" rowspan="1" align="center" valign="top"> 66 &#177; 21<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND<xref ref-type="table-fn" rid="tblfn5"><italic>e</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> ND </td><td colspan="1" rowspan="1" align="center" valign="top"> 2076 &#177; 485%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 15 &#177; 4%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;K69C </td><td colspan="1" rowspan="1" align="center" valign="top"> 821 &#177; 146 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 350 &#177; 50%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 1 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;F185C </td><td colspan="1" rowspan="1" align="center" valign="top"> 587 &#177; 224 </td><td colspan="1" rowspan="1" align="center" valign="top"> 265 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.58 &#177; 0.07<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 93 &#177; 7% </td><td colspan="1" rowspan="1" align="center" valign="top"> 95 &#177; 2% </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;T186C </td><td colspan="1" rowspan="1" align="center" valign="top"> 1706 &#177; 425 </td><td colspan="1" rowspan="1" align="center" valign="top"> 650 &#956;<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> 3.19 &#177; 0.04<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 35 &#177; 6%<xref ref-type="table-fn" rid="tblfn4"><italic>d</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 8 &#177; 3%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;N293C </td><td colspan="1" rowspan="1" align="center" valign="top"> 521 &#177; 164 </td><td colspan="1" rowspan="1" align="center" valign="top"> &gt;3 m<sc>m</sc></td><td colspan="1" rowspan="1" align="center" valign="top"> &lt;2.52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6 &#177; 1%<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2 &#177; 1<xref ref-type="table-fn" rid="tblfn3"><italic>c</italic></xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p textid="26">NF, nonfunctional.</p></fn><fn id="tblfn2"><label>b</label><p textid="27"><italic>p</italic> &lt; 0.01, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn3"><label>c</label><p textid="28"><italic>p</italic> &lt; 0.001, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn4"><label>d</label><p textid="29"><italic>p</italic> &lt; 0.05, <italic>n</italic> = 3-18.</p></fn><fn id="tblfn5"><label>e</label><p textid="30">ND, not determined.</p></fn></table-wrap-foot></table-wrap>
TABLE 1Summary of the effects of cysteine substitution on P2X2 and P2X4Peak current values taken on 1st application of a maximal concentration of ATP (a saturating concentration 300 mum to 10 mm). pEC50 values shown as calculated from experimental data. pEC50 is -log10 of the EC50. MTS data (effect of ATP applied in the presence of MTS reagent) calculated as a percentage of the control (effect of ATP applied in the absence of MTS reagent) which was set as 100%.nA (max)EC50pEC50MTSEAMTSESHuman P2X2     WT  4465 +/- 477  13 mum 4.89 +/- 0.1  127 +/- 2%  101 +/- 3%      K69C  NFa NF  NF  No effect  No effect      K71C  NF  NF  NF  No effect  No effect      F183C  4661 +/- 1209  40 mum 4.40 +/- 0.1b 128 +/- 2%  96 +/- 1%      T184C  4515 +/- 1402  117 mum 3.93 +/- 0.1c 195 +/- 11%d 20 +/- 3%c     N288C  13 +/- 2b >3 mm <2.52  22 +/- 5%b 21 +/- 3%c     F289C  2279 +/- 583  64 mum 4.19 +/- 0.1c 123 +/- 11%  78 +/- 11%d     R290C  525 +/- 70d >3 mm <2.52  1237 +/- 249%c 27 +/- 7%c     K307C  49 +/- 20c >3 mm <2.52  27500 +/- 6660%c 15 +/- 1%cRat P2X4-myc (Y378A)     WT  2513 +/- 187  13 mum 4.89 +/- 0.02  103 +/- 11%  108 +/- 6%      K67C  66 +/- 21d NDe ND  2076 +/- 485%c 15 +/- 4%c     K69C  821 +/- 146  >3 mm <2.52  350 +/- 50%c 1 +/- 1%c     F185C  587 +/- 224  265 mum 3.58 +/- 0.07c 93 +/- 7%  95 +/- 2%      T186C  1706 +/- 425  650 mum 3.19 +/- 0.04c 35 +/- 6%d 8 +/- 3%c     N293C  521 +/- 164  >3 mm <2.52  6 +/- 1%c 2 +/- 1caNF, nonfunctional.bp < 0.01, n = 3-18.cp < 0.001, n = 3-18.dp < 0.05, n = 3-18.eND, not determined.
###end p 23
###begin p 24
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of the effects of cysteine substitution on P2X<sub>2</sub> and P2X<sub>4</sub></bold>
Summary of the effects of cysteine substitution on P2X2 and P2X4
###end p 24
###begin p 25
###xml 113 114 112 113 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 122 123 121 122 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 129 131 128 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 186 188 185 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 208 210 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
Peak current values taken on 1st application of a maximal concentration of ATP (a saturating concentration 300 mum to 10 mm). pEC50 values shown as calculated from experimental data. pEC50 is -log10 of the EC50. MTS data (effect of ATP applied in the presence of MTS reagent) calculated as a percentage of the control (effect of ATP applied in the absence of MTS reagent) which was set as 100%.
###end p 25
###begin p 26
NF, nonfunctional.
###end p 26
###begin p 27
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
p < 0.01, n = 3-18.
###end p 27
###begin p 28
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
p < 0.001, n = 3-18.
###end p 28
###begin p 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
p < 0.05, n = 3-18.
###end p 29
###begin p 30
ND, not determined.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 9 64 9 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of point cysteine P2X<sub>2</sub> mutations on ATP potency.</bold>
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 777 778 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 853 854 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 903 914 903 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 9 985 9 985 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Effect of point cysteine P2X<sub>2</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>2</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential =&#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by the <italic>bar</italic>, concentrations in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K69C, K71C, F183C, T184C, N288C, F289C, R290C, and K307C. K69C, K71C, N288C, and K307C with reduced peak currents in response to a maximal concentration of ATP, are expressed as a percentage of the amplitude of the WT maximum response, whereas all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;10). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>2</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p>
###xml 9 985 9 985 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Effect of point cysteine P2X<sub>2</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>2</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential =&#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by the <italic>bar</italic>, concentrations in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K69C, K71C, F183C, T184C, N288C, F289C, R290C, and K307C. K69C, K71C, N288C, and K307C with reduced peak currents in response to a maximal concentration of ATP, are expressed as a percentage of the amplitude of the WT maximum response, whereas all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;10). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>2</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p></caption>
###xml 985 985 985 985 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800002"/>
###xml 0 985 0 985 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="32"><bold>Effect of point cysteine P2X<sub>2</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>2</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential =&#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by the <italic>bar</italic>, concentrations in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K69C, K71C, F183C, T184C, N288C, F289C, R290C, and K307C. K69C, K71C, N288C, and K307C with reduced peak currents in response to a maximal concentration of ATP, are expressed as a percentage of the amplitude of the WT maximum response, whereas all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;10). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>2</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p></caption><graphic xlink:href="zbc0320843800002"/></fig>
FIGURE 2.Effect of point cysteine P2X2 mutations on ATP potency. ATP potency was tested on WT and P2X2 receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential =-60 mV). A, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by the bar, concentrations in micromolar) at 5-min intervals. B, concentration-response curves to ATP for WT and mutants K69C, K71C, F183C, T184C, N288C, F289C, R290C, and K307C. K69C, K71C, N288C, and K307C with reduced peak currents in response to a maximal concentration of ATP, are expressed as a percentage of the amplitude of the WT maximum response, whereas all others are expressed as a percentage of their own maximum response (n = 3-10). C, Western blots of total and surface expression levels of WT and mutant P2X2 receptors with reduced peak current amplitudes. Lower panel shows densitometric analysis of the blots expressed as % of WT levels.
###end p 31
###begin p 32
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of point cysteine P2X<sub>2</sub> mutations on ATP potency.</bold>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 327 330 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 768 769 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 844 845 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 894 905 894 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
Effect of point cysteine P2X2 mutations on ATP potency. ATP potency was tested on WT and P2X2 receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential =-60 mV). A, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by the bar, concentrations in micromolar) at 5-min intervals. B, concentration-response curves to ATP for WT and mutants K69C, K71C, F183C, T184C, N288C, F289C, R290C, and K307C. K69C, K71C, N288C, and K307C with reduced peak currents in response to a maximal concentration of ATP, are expressed as a percentage of the amplitude of the WT maximum response, whereas all others are expressed as a percentage of their own maximum response (n = 3-10). C, Western blots of total and surface expression levels of WT and mutant P2X2 receptors with reduced peak current amplitudes. Lower panel shows densitometric analysis of the blots expressed as % of WT levels.
###end p 32
###begin p 33
###xml 46 47 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 57 0 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effects of MTS Reagents on Cysteine Mutant P2X<sub>2</sub> Receptors</italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
Effects of MTS Reagents on Cysteine Mutant P2X2 Receptors-At P2X receptors the 10 conserved cysteine residues in the extracellular domain are thought to form five intrasubunit disulfide bonds (25, 27). The substituted cysteine accessibility method has been used to look at the contribution of introduced cysteine mutants to receptor function, where modification of properties following application of MTS reagents indicates that the introduced cysteine residue is accessible in the aqueous environment and may play an important role in receptor function (28). Previously, charged MTS reagents (positively charged MTSEA and negatively charged sodium MTSES), have been used to probe residues involved in ATP action at P2X receptors (15, 16) as they may interact with the negative charge of the phosphate tail of ATP or magnesium complexed with ATP in physiological solutions giving rise to localized positive charge.
###end p 33
###begin p 34
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 31 32 31 32 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 108 110 106 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 133 140 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 142 148 140 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 192 194 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 196 198 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 361 362 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 374 381 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 383 389 381 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 744 746 738 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 769 776 763 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 778 784 772 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
At WT P2X2 receptors MTSEA (1 mm) produced a small increase (128 +/- 3% of control) in the response to an EC50 concentration of ATP (Table 1, Fig. 3) as reported previously for this receptor (13, 14). MTSEA had no effect on the potency of ATP and current amplitudes returned to control levels on washout. MTSEA had a similar effect at F183C and F289C mutant P2X2 receptors (Table 1, Fig. 3). At T184C there was an increase in potentiation to 195 +/- 11% of control, however, on washout this was reduced to 141 +/- 11% of control indicating that it results from a combination of the reversible effect seen for WT and an additional irreversible modification. R290C and K307C MTSEA produced a significantly larger increase in the response to an EC50 concentration of ATP (Table 1, Fig. 3) that was sustained on washout indicating that it results from irreversible modification of the introduced cysteine.
###end p 34
###begin p 35
###xml 92 93 92 93 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 424 426 424 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 532 533 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 553 554 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 563 569 559 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 618 619 614 615 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 729 730 713 714 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 867 869 851 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 920 921 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1237 1238 1219 1220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
At R290C the amplitude of responses was still rising in response to increases from 3 to 10 mm ATP, indicating a large decrease in ATP sensitivity at this mutant. MTSEA application for 10 min in the absence of agonist resulted in a large increase in amplitude of responses and a leftward shift in the concentration response to ATP and now a fully saturating concentration response was generated following MTSEA treatment (pEC50 values 2.8 +/- 0.1, estimated from a free fit as responses did not saturate for control, to 3.3 +/- 0.2, p < 0.01, for MTSEA, n = 3-4) (Fig. 4). Responses to a high concentration of ATP (10 mm) were small (approximately50 nA) for the K307C mutant and responses were below the limit of detection for 1 mm ATP, however, following a 10-min MTSEA treatment (and washout) there was a very large increase in the amplitude of responses and the pEC50 for ATP in the presence of MTSEA was 3.5 +/- 0.1 (n = 7). As MTSEA was able to rescue the responses to mutants with small amplitude currents we tested whether MTSEA had any effect on mutants where receptor protein could be detected at the cell surface but little or no current was detected in response to high concentrations of ATP. At N288C the responses to ATP (3 mm) were reduced to 22 +/- 5% of control following MTSEA treatment, this effect was sustained on MTSEA washout. For mutants K69C and K71C, ATP-evoked currents were still not detected following MTSEA treatment.
###end p 35
###begin p 36
###xml 45 46 45 46 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 105 111 105 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 222 229 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 231 237 231 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 298 300 298 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 449 456 425 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 458 464 434 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 690 691 666 667 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
The negatively charged MTS reagent MTSES (1 mm) had no effect on currents at WT P2X2 receptors (Table 1, Fig. 3) as described previously (15). Similarly MTSES had no effect on ATP responses at F183C mutant P2X2 receptors (Table 1, Fig. 3). MTSES, however, reduced the amplitude of response to an EC50 concentration of ATP by approximately80% for mutants T184C, N288C, R290C, and K307C, a more modest approximately20% decrease was recorded at F289C (Table 1, Fig. 3). These effects were maintained following washout of MTSES indicating that the reagent was acting irreversibly to modify the introduced cysteine residues. For non-functional mutants K69C and K71C in the presence of MTSES, 3 mm ATP still did not evoke a response.
###end p 36
###begin p 37
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 62 0 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Cysteine Mutants on ATP Responses at P2X<sub>4</sub> Receptors</italic>
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 396 397 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 427 429 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 451 452 438 439 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 454 461 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 463 469 450 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 518 519 505 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 531 533 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 534 536 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 583 584 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 753 755 740 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 830 837 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 839 845 814 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 991 992 966 967 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1026 1028 1001 1003 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1048 1049 1023 1024 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1051 1058 1026 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1060 1066 1035 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1273 1274 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1267 1274 1242 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1422 1429 1397 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4C</xref>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 389 392 <span type="species:ncbi:10116">rat</span>
###xml 511 514 <span type="species:ncbi:10116">rat</span>
Effects of Cysteine Mutants on ATP Responses at P2X4 Receptors-The myc-tagged rat P2X4 receptor with the Y378A mutation was used as the background for these studies. The Y378A mutation was introduced to improve surface expression of the receptor (21) and increased the peak amplitude of ATP currents by >20-50-fold in the present study. ATP evoked concentration-dependent responses at the rat P2X4-myc Y378C receptor with an EC50 of approximately13 mum (Table 1, Fig. 5) similar to that reported previously for rat P2X4 receptors (29-31) and this construct will be referred to as P2X4 WT. At all cysteine mutants tested there was a decrease in ATP potency. For F185C, T186C, and F294C mutants full concentration-response curves were generated and the EC50 for ATP was increased by approximately20-, 50-, and 4-fold, respectively (Table 1, Fig. 5). For the remaining mutants (K67C, K69C, N293C, R295C, and K313C) ATP-evoked responses did not saturate at the maximum concentration tested (10 mm) and for these mutants the ATP EC50 is reported as >3 mm (Table 1, Fig. 5). Mutants K67C, R295C, and K313C had reduced maximal current amplitudes compared with WT, however, this was not reflected by a marked reduction in either total or surface expression of the receptors (Fig. 4C). For the mutant N293C the smaller peak current amplitudes may result in part from a reduction in trafficking of the receptor to the cell surface (Fig. 4C).
###end p 37
###begin p 38
###xml 46 47 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 57 0 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effects of MTS Reagents on Cysteine Mutant P2X<sub>4</sub> Receptors</italic>
###xml 87 88 87 88 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 158 164 158 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 356 362 356 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 410 412 410 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 549 556 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 558 564 534 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 661 663 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">67</sup>
###xml 668 670 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">69</sup>
###xml 679 682 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">313</sup>
###xml 752 759 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 761 767 737 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
Effects of MTS Reagents on Cysteine Mutant P2X4 Receptors-Positively charged MTSEA (1 mm) had no effect on ATP-evoked currents at WT P2X4 receptors (Table 1, Fig. 6) consistent with that described previously (17). ATP-evoked responses were also unaffected by MTSEA for the mutants of the conserved aromatic phenylalanine residues F185C and F294C (Table 1, Fig. 6). At T186C and R295C, responses evoked by an EC50 concentration of ATP were reduced to approximately40% of control levels and at mutant N293C responses were reduced by approximately95% (Table 1, Fig. 6). In contrast, at mutants where a positively charged lysine residue was mutated to cysteine (Lys67, Lys69, and Lys313) application of MTSEA potentiated the amplitude of the ATP response (Table 1, Fig. 6).
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 9 75 9 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP responses of P2X<sub>2</sub> cysteine mutants.</bold>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 169 170 169 170 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 192 194 192 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 488 489 488 489 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 511 513 511 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 549 552 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 730 731 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 770 771 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 784 785 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 799 800 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 9 809 9 809 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>Effect of MTS compounds on ATP responses of P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed before and during the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). <italic>C</italic>, trace data representative of currents observed with the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent applied in a similar manner to MTSEA traces are shown for a given oocyte before and during MTSES application. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
###xml 9 809 9 809 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>Effect of MTS compounds on ATP responses of P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed before and during the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). <italic>C</italic>, trace data representative of currents observed with the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent applied in a similar manner to MTSEA traces are shown for a given oocyte before and during MTSES application. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p></caption>
###xml 809 809 809 809 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800003"/>
###xml 0 809 0 809 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="40"><bold>Effect of MTS compounds on ATP responses of P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed before and during the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). <italic>C</italic>, trace data representative of currents observed with the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent applied in a similar manner to MTSEA traces are shown for a given oocyte before and during MTSES application. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>2</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p></caption><graphic xlink:href="zbc0320843800003"/></fig>
FIGURE 3.Effect of MTS compounds on ATP responses of P2X2 cysteine mutants.A, trace data representative of currents observed before and during the addition of MTSEA (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. B, graph representing the effect of MTSEA on the P2X2 WT and mutant receptors (n = 3-6). C, trace data representative of currents observed with the addition of MTSES (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSES reagent applied in a similar manner to MTSEA traces are shown for a given oocyte before and during MTSES application. D, graph representing the effect of MTSES on the P2X2 WT and mutant receptors (n = 3-6). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 39
###begin p 40
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP responses of P2X<sub>2</sub> cysteine mutants.</bold>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 160 161 160 161 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 183 185 183 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 479 480 479 480 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 502 504 502 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 669 670 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 721 722 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 775 776 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 790 791 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Effect of MTS compounds on ATP responses of P2X2 cysteine mutants.A, trace data representative of currents observed before and during the addition of MTSEA (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. B, graph representing the effect of MTSEA on the P2X2 WT and mutant receptors (n = 3-6). C, trace data representative of currents observed with the addition of MTSES (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSES reagent applied in a similar manner to MTSEA traces are shown for a given oocyte before and during MTSES application. D, graph representing the effect of MTSES on the P2X2 WT and mutant receptors (n = 3-6). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 9 73 9 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP potency at P2X<sub>2</sub> cysteine mutants.</bold>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 215 216 215 216 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 370 371 370 371 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 461 462 461 462 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 492 9 492 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>Effect of MTS compounds on ATP potency at P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, ATP concentration-response curve for R290C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;4). <italic>B</italic>, ATP concentration-response curve for K307C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;6). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP under control conditions.</p>
###xml 9 492 9 492 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>Effect of MTS compounds on ATP potency at P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, ATP concentration-response curve for R290C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;4). <italic>B</italic>, ATP concentration-response curve for K307C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;6). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP under control conditions.</p></caption>
###xml 492 492 492 492 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800004"/>
###xml 0 492 0 492 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="42"><bold>Effect of MTS compounds on ATP potency at P2X<sub>2</sub> cysteine mutants.</bold><italic>A</italic>, ATP concentration-response curve for R290C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;4). <italic>B</italic>, ATP concentration-response curve for K307C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 m<sc>m</sc>)(<italic>n</italic> = 3&#8211;6). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP under control conditions.</p></caption><graphic xlink:href="zbc0320843800004"/></fig>
FIGURE 4.Effect of MTS compounds on ATP potency at P2X2 cysteine mutants.A, ATP concentration-response curve for R290C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 mm)(n = 3-4). B, ATP concentration-response curve for K307C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 mm)(n = 3-6). The data are expressed as a percentage of the amplitude of the response to 3 mm ATP under control conditions.
###end p 41
###begin p 42
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP potency at P2X<sub>2</sub> cysteine mutants.</bold>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 206 207 206 207 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 361 362 361 362 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 452 453 452 453 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Effect of MTS compounds on ATP potency at P2X2 cysteine mutants.A, ATP concentration-response curve for R290C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 mm)(n = 3-4). B, ATP concentration-response curve for K307C under control conditions or following washout of MTSEA after a 10-min incubation with MTSEA (1 mm)(n = 3-6). The data are expressed as a percentage of the amplitude of the response to 3 mm ATP under control conditions.
###end p 42
###begin p 43
###xml 48 49 48 49 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 163 169 163 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
The application of negatively charged MTSES (1 mm) had no effect on the amplitude of ATP evoked responses at WT or F185C and F294C mutant P2X4 receptors (Table 1, Fig. 6). At the remainder of the mutants (K67C, K69C, T186C, N293C, R295C, and K313C) MTSES reduced the amplitude of ATP evoked responses by approximately80-95%. These results suggest that the negative charge at this position interferes with the action of ATP possibly by repelling the negatively charged phosphate tail.
###end p 43
###begin p 44
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 440 441 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 857 858 857 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 902 903 902 903 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1081 1082 1081 1082 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1425 1426 1413 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1483 1484 1471 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1783 1784 1771 1772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1980 1981 1968 1969 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2043 2045 2031 2033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">69</sup>
###xml 2053 2055 2041 2043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">71</sup>
###xml 2076 2078 2064 2066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 2122 2123 2110 2111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2280 2282 2268 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
These effects of MTSEA and MTSES are broadly consistent for both the P2X2 and P2X4 receptors. However, in contrast to the P2X2 receptor the effects of MTS reagents were reversible on washout (showing 50-100% recovery following 5 min washout) indicating that either the reagent was not irreversibly modifying the receptor or that un-modified receptors were being trafficked to the cell surface during the washout period. It is known that P2X4 receptors undergo cyclical trafficking to the cell surface (21, 23, 24) so we decided to see whether longer incubation with the MTS reagents had an irreversible effect. In addition, as the MTS reagents were applied before and during ATP application the question arises as to whether the introduced cysteines are accessible in the un-liganded or ligand bound state. To address these questions we incubated mutant P2X4 receptors in membrane impermeant MTSES (1 mm) in the presence of apyrase (3.2 units/ml to break down any endogenous ATP in the solutions) for 3 h followed by washing. This treatment had no effect on the amplitude of WT P2X4 receptors compared with oocytes treated with just apyrase. For the mutants, however, there was a significant reduction in the amplitude of responses for the mutants K67C, K69C, T186C, N293C, R295C, and K313C (8 +/- 1, 10 +/- 3, 10 +/- 3, 35 +/- 8, 25 +/- 6, and 17 +/- 4.7% of ATP responses following apyrase treatment only and washing, with p < 0.01, 0.001, 0.005, 0.005, 0.005, 0.01, respectively, n = 4-7). These results show that longer incubations with MTS reagents are required to irreversibly modify the receptors, give equivalent results to bath-applied MTSES, and suggest that washout following short applications of MTS reagents (5-10 min) results from trafficking of un-modified mutant P2X4 receptors to the cell surface. These results also demonstrate that these introduced cysteine residues are accessible in the absence of agonist. This is consistent with previous studies on the P2X2 receptor indicating that MTS effects at the region around Lys69 and Lys71 are blocked by ATP (15) and MTSEA biotinylation studies on the P2X1 receptor showing that mutants N290C, F291C, R292C, and K309C are MTSEA biotinylated in the absence of ATP and this is reduced following application of ATP (16). Taken together these results show that the MTS reagents are acting at introduced cysteine residues that are accessible in the absence of ligand.
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 9 64 9 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of point cysteine P2X<sub>4</sub> mutations on ATP potency.</bold>
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 758 759 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 768 769 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 844 845 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 894 905 894 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 9 976 9 976 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>Effect of point cysteine P2X<sub>4</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>4</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential = &#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by <italic>bar</italic>, concentration in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K67C, K69C, F185C, T186C, N293C, F294C, R295C, and K313C. K67C, K69C, N293C, R295C, and K313C, with reduced peak currents in response to a maximal concentration of ATP, are all expressed as a percentage of peak WT maximum response whereas, all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;4). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>4</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p>
###xml 9 976 9 976 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>Effect of point cysteine P2X<sub>4</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>4</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential = &#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by <italic>bar</italic>, concentration in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K67C, K69C, F185C, T186C, N293C, F294C, R295C, and K313C. K67C, K69C, N293C, R295C, and K313C, with reduced peak currents in response to a maximal concentration of ATP, are all expressed as a percentage of peak WT maximum response whereas, all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;4). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>4</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p></caption>
###xml 976 976 976 976 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800005"/>
###xml 0 976 0 976 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="46"><bold>Effect of point cysteine P2X<sub>4</sub> mutations on ATP potency.</bold> ATP potency was tested on WT and P2X<sub>4</sub> receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential = &#8211;60 mV). <italic>A</italic>, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by <italic>bar</italic>, concentration in micromolar) at 5-min intervals. <italic>B</italic>, concentration-response curves to ATP for WT and mutants K67C, K69C, F185C, T186C, N293C, F294C, R295C, and K313C. K67C, K69C, N293C, R295C, and K313C, with reduced peak currents in response to a maximal concentration of ATP, are all expressed as a percentage of peak WT maximum response whereas, all others are expressed as a percentage of their own maximum response (<italic>n</italic> = 3&#8211;4). <italic>C</italic>, Western blots of total and surface expression levels of WT and mutant P2X<sub>4</sub> receptors with reduced peak current amplitudes. <italic>Lower panel</italic> shows densitometric analysis of the blots expressed as % of WT levels.</p></caption><graphic xlink:href="zbc0320843800005"/></fig>
FIGURE 5.Effect of point cysteine P2X4 mutations on ATP potency. ATP potency was tested on WT and P2X4 receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential = -60 mV). A, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by bar, concentration in micromolar) at 5-min intervals. B, concentration-response curves to ATP for WT and mutants K67C, K69C, F185C, T186C, N293C, F294C, R295C, and K313C. K67C, K69C, N293C, R295C, and K313C, with reduced peak currents in response to a maximal concentration of ATP, are all expressed as a percentage of peak WT maximum response whereas, all others are expressed as a percentage of their own maximum response (n = 3-4). C, Western blots of total and surface expression levels of WT and mutant P2X4 receptors with reduced peak current amplitudes. Lower panel shows densitometric analysis of the blots expressed as % of WT levels.
###end p 45
###begin p 46
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of point cysteine P2X<sub>4</sub> mutations on ATP potency.</bold>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 324 327 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 749 750 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 759 760 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 835 836 835 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 885 896 885 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
Effect of point cysteine P2X4 mutations on ATP potency. ATP potency was tested on WT and P2X4 receptor mutants expressed in oocytes by two-electrode voltage clamp (holding potential = -60 mV). A, trace data representative of currents observed for wild type and mutant receptors in response to ATP applications (indicated by bar, concentration in micromolar) at 5-min intervals. B, concentration-response curves to ATP for WT and mutants K67C, K69C, F185C, T186C, N293C, F294C, R295C, and K313C. K67C, K69C, N293C, R295C, and K313C, with reduced peak currents in response to a maximal concentration of ATP, are all expressed as a percentage of peak WT maximum response whereas, all others are expressed as a percentage of their own maximum response (n = 3-4). C, Western blots of total and surface expression levels of WT and mutant P2X4 receptors with reduced peak current amplitudes. Lower panel shows densitometric analysis of the blots expressed as % of WT levels.
###end p 46
###begin p 47
###xml 416 418 416 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 518 519 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 536 542 530 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
For mutants K67C, K69C, and K313, where MTSEA resulted in an increase in the amplitude of the response to ATP we constructed concentration-response curves following application of MTSEA. We found that incubation with membrane-permeant MTSEA for 1 h (in the absence of agonist) followed by washout and testing of ATP sensitivity in the absence of MTSEA resulted in an increase in ATP potency at the receptors with pEC50 values of 3.61 +/- 0.24, 3.95 +/- 0.09, and 3.63 +/- 0.16 for K67C, K69C, and K313C, respectively (n = 4, 3, and 3) (Fig. 7). These results suggest that positive charge at these positions plays an important role in determining ATP potency.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 396 397 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
The aim of this study was to determine whether a model of the ATP binding site based on systematic mutagenesis studies on the P2X1 receptor could be applied, using cysteine-based mutagenesis, to other P2X receptor family members, and to extend this to see if the actions of ATP could be modified in a similar way by MTS reagents. The data for the effects of cysteine mutants on ATP potency at P2X2 and P2X4 receptors support previous work about residues involved in ATP action.
###end p 49
###begin p 50
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 9 75 9 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP responses of P2X<sub>4</sub> cysteine mutants.</bold>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 154 155 154 155 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 177 179 177 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 454 455 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 570 571 570 571 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 593 595 593 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 631 634 631 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 843 844 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 870 871 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 897 898 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 912 913 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 9 922 9 922 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51"><bold>Effect of MTS compounds on ATP responses of P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed on the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;8). <italic>C</italic>, trace data representative of currents observed on the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent was applied in a similar manner to MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSES. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p>
###xml 9 922 9 922 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="51"><bold>Effect of MTS compounds on ATP responses of P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed on the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;8). <italic>C</italic>, trace data representative of currents observed on the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent was applied in a similar manner to MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSES. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p></caption>
###xml 922 922 922 922 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800006"/>
###xml 0 922 0 922 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="51"><bold>Effect of MTS compounds on ATP responses of P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, trace data representative of currents observed on the addition of MTSEA (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSEA. <italic>B</italic>, graph representing the effect of MTSEA on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;8). <italic>C</italic>, trace data representative of currents observed on the addition of MTSES (1 m<sc>m</sc>). ATP application (EC<sub>50</sub> concentration) is indicated by the <italic>bar</italic>. MTSES reagent was applied in a similar manner to MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSES. <italic>D</italic>, graph representing the effect of MTSES on the P2X<sub>4</sub> WT and mutant receptors (<italic>n</italic> = 3&#8211;6). *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001.</p></caption><graphic xlink:href="zbc0320843800006"/></fig>
FIGURE 6.Effect of MTS compounds on ATP responses of P2X4 cysteine mutants.A, trace data representative of currents observed on the addition of MTSEA (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSEA. B, graph representing the effect of MTSEA on the P2X4 WT and mutant receptors (n = 3-8). C, trace data representative of currents observed on the addition of MTSES (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSES reagent was applied in a similar manner to MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSES. D, graph representing the effect of MTSES on the P2X4 WT and mutant receptors (n = 3-6). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 50
###begin p 51
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP responses of P2X<sub>4</sub> cysteine mutants.</bold>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 145 146 145 146 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 168 170 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 445 446 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 561 562 561 562 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 584 586 584 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 622 625 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar</italic>
###xml 782 783 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 834 835 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 874 875 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 903 904 903 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Effect of MTS compounds on ATP responses of P2X4 cysteine mutants.A, trace data representative of currents observed on the addition of MTSEA (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSEA reagent was bath applied 5 min prior to U-tube ATP coapplication with MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSEA. B, graph representing the effect of MTSEA on the P2X4 WT and mutant receptors (n = 3-8). C, trace data representative of currents observed on the addition of MTSES (1 mm). ATP application (EC50 concentration) is indicated by the bar. MTSES reagent was applied in a similar manner to MTSEA. Traces are shown in response to ATP for a given oocyte before and during the application of MTSES. D, graph representing the effect of MTSES on the P2X4 WT and mutant receptors (n = 3-6). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 51
###begin p 52
###xml 307 309 307 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 317 318 317 318 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 919 920 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1056 1061 1056 1061 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,2,4</sub>
###xml 1163 1166 1163 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">309</sup>
###xml 1177 1178 1177 1178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1324 1325 1324 1325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1571 1572 1571 1572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1725 1727 1713 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1785 1786 1773 1774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1800 1801 1788 1789 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1942 1943 1930 1931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2102 2104 2078 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 2106 2108 2082 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 2238 2240 2214 2216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 2383 2384 2359 2360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2395 2397 2371 2373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 2444 2445 2420 2421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2456 2458 2432 2434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 2494 2495 2470 2471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2590 2591 2566 2567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
There are three conserved lysine residues in the extracellular domain that have been suggested to be involved in ATP binding at P2X receptors. Mutagenesis of these residues has shown a marked decrease in agonist potency at a variety of receptors with the majority of the mutations resulting in a shift in EC50 to >3 mm and in some cases, e.g. P2X2 receptors, currents are below the limit of detection even at high agonist concentrations (15). At P2X4 receptors ATP sensitivity at K67C, K69C, and K313C was increased on treatment with MTSEA, consistent with the fact that the incorporation of MTSEA at cysteine produces a side chain of similar size and charge to lysine (17). In contrast, responses were reduced by 80-95% following treatment with negatively charged MTSES. This clearly indicates that the localized charge at these three positions plays an important role in regulating ATP action at the receptor. For P2X2 receptors a response to ATP was not evoked even following MTS treatment at mutants K69C and K71C. One feature that is common to the P2X1,2,4 receptors is that the decrease in ATP potency at the cysteine mutant of the residue equivalent to Lys309 in the P2X1 receptor can be rescued by treatment with MTSEA, consistent with an important role of positive charge at this position. A recent study on the P2X2 receptor using single channel analysis has suggested the lysine residue 308 can play a role in regulation of gating of the channel. This was based on the fact that mutation of this residue could abolish spontaneous gating of the T339S mutant P2X2 channel and that mutation K308R reduced ATP potency by approximately200-fold and decreased the amplitude of the maximal response compared with control (32). In the current study the concentration responses to P2X2 K307C and P2X4 K313C did not saturate so it is not possible to determine whether there was a reduction in the amplitude of the maximal response. At the P2X1 receptor the approximately200-fold reduction in ATP potency at K309R and K309C mutants did not result in a decrease in the amplitude of the maximal response (16, 22) as would have been expected if an effect on gating of the receptor has been primarily responsible for the reduction in potency (33). These results suggest that the effects of mutation of this conserved residue can be manifest as a principal effect on ATP binding at the P2X1 receptor (16) and an additional effect on gating at the P2X2 receptor (32). This may indicate that in the P2X2 receptor the lysine residue interacts with another amino acid that is not conserved at the P2X1 receptor to regulate gating. Taken together these results support that the three positively charged lysine residues play an important role in ATP action most likely contributing to the ATP binding site. Indeed it would be unusual to have an ATP-binding protein without positive charge being important in coordinating agonist binding.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 9 73 9 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP potency at P2X<sub>4</sub> cysteine mutants.</bold>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 434 435 434 435 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 465 466 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 672 673 672 673 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 723 9 723 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Effect of MTS compounds on ATP potency at P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K67C mutants. <italic>B</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K69C mutants. <italic>C</italic>, MTSEA significantly increased ATP potency and peak response at K313C mutants (<italic>n</italic> = 3&#8211;4). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP. For MTSEA treatment (1 m<sc>m</sc>, 1 h incubation, followed by washout and construction of the concentration response in the absence of MTSEA) these have been corrected with a scaling factor corresponding to the mean -fold increase, at 3 m<sc>m</sc> ATP, in currents compared with untreated oocytes.</p>
###xml 9 723 9 723 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Effect of MTS compounds on ATP potency at P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K67C mutants. <italic>B</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K69C mutants. <italic>C</italic>, MTSEA significantly increased ATP potency and peak response at K313C mutants (<italic>n</italic> = 3&#8211;4). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP. For MTSEA treatment (1 m<sc>m</sc>, 1 h incubation, followed by washout and construction of the concentration response in the absence of MTSEA) these have been corrected with a scaling factor corresponding to the mean -fold increase, at 3 m<sc>m</sc> ATP, in currents compared with untreated oocytes.</p></caption>
###xml 723 723 723 723 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800007"/>
###xml 0 723 0 723 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="54"><bold>Effect of MTS compounds on ATP potency at P2X<sub>4</sub> cysteine mutants.</bold><italic>A</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K67C mutants. <italic>B</italic>, MTSEA significantly increased the potency of ATP and amplitude of responses at K69C mutants. <italic>C</italic>, MTSEA significantly increased ATP potency and peak response at K313C mutants (<italic>n</italic> = 3&#8211;4). The data are expressed as a percentage of the amplitude of the response to 3 m<sc>m</sc> ATP. For MTSEA treatment (1 m<sc>m</sc>, 1 h incubation, followed by washout and construction of the concentration response in the absence of MTSEA) these have been corrected with a scaling factor corresponding to the mean -fold increase, at 3 m<sc>m</sc> ATP, in currents compared with untreated oocytes.</p></caption><graphic xlink:href="zbc0320843800007"/></fig>
FIGURE 7.Effect of MTS compounds on ATP potency at P2X4 cysteine mutants.A, MTSEA significantly increased the potency of ATP and amplitude of responses at K67C mutants. B, MTSEA significantly increased the potency of ATP and amplitude of responses at K69C mutants. C, MTSEA significantly increased ATP potency and peak response at K313C mutants (n = 3-4). The data are expressed as a percentage of the amplitude of the response to 3 mm ATP. For MTSEA treatment (1 mm, 1 h incubation, followed by washout and construction of the concentration response in the absence of MTSEA) these have been corrected with a scaling factor corresponding to the mean -fold increase, at 3 mm ATP, in currents compared with untreated oocytes.
###end p 53
###begin p 54
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of MTS compounds on ATP potency at P2X<sub>4</sub> cysteine mutants.</bold>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 425 426 425 426 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 456 457 456 457 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 663 664 663 664 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Effect of MTS compounds on ATP potency at P2X4 cysteine mutants.A, MTSEA significantly increased the potency of ATP and amplitude of responses at K67C mutants. B, MTSEA significantly increased the potency of ATP and amplitude of responses at K69C mutants. C, MTSEA significantly increased ATP potency and peak response at K313C mutants (n = 3-4). The data are expressed as a percentage of the amplitude of the response to 3 mm ATP. For MTSEA treatment (1 mm, 1 h incubation, followed by washout and construction of the concentration response in the absence of MTSEA) these have been corrected with a scaling factor corresponding to the mean -fold increase, at 3 mm ATP, in currents compared with untreated oocytes.
###end p 54
###begin p 55
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 529 530 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1036 1037 1036 1037 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
The mutations of conserved aromatics F183C in P2X2 and F185C in the P2X4 receptor gave rise to a modest 3- and 20-fold decrease in ATP potency at the receptors. This is consistent with previous studies on P2X1 and P2X4 receptors (34, 35) and indicates that this conserved residue contributes to ATP action. The MTS reagents used are of similar size (or smaller) than ATP and can gain access to the ATP binding pocket. The effects of the MTS compounds at cysteine mutants of the adjacent threonine residue (T184C and T186C for P2X2 and P2X4, respectively) suggest that this region of the receptor is accessible to these reagents and the lack of effect at the cysteine-substituted phenylalanine residues is likely to reflect that this residue is either not very close to the ATP binding pocket or is involved in interaction with other residues that could regulate gating. The former interpretation suggests that the phenylalanine may not play a direct role in binding of the adenine ring of ATP as we have suggested previously for the P2X1 receptor (34). However, cysteine substitution does give rise to changes in agonist action at the receptor. The introduction of a polar side chain (cysteine) to replace the non-polar phenylalanine could have an effect on bonding/electrostatic interactions or a structural change to the receptor.
###end p 55
###begin p 56
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 280 282 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 361 362 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 428 429 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 437 438 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 456 457 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 465 466 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 772 775 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">190</sup>
###xml 782 783 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 791 794 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">188</sup>
###xml 801 802 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 862 864 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 918 920 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
Mutation of threonine in the conserved FT motif to cysteine resulted in a 10- and 40-fold decrease in ATP potency at P2X2 and P2X4 receptors. Previous studies on the P2X2 receptor have shown that alanine substitution at this residue deceases ATP potency by approximately100-fold (15). This is the first time a mutation has been made at this position for the P2X4 receptors and it supports a similar mode of agonist action as P2X1 and P2X2 receptors. At P2X2 and P2X4 receptors the response was inhibited by MTSES. These results clearly indicate that modification of the side chain at this conserved threonine residue can regulate channel function. Close to the FT motif is a nearby conserved lysine residue that has been shown to be involved in regulating ATP potency (Lys190 in P2X1 and Lys188 in P2X2 that when mutated to alanine resulted in approximately10- (22) and approximately100-fold decreases in ATP potency (36)). Thus this region in the middle of the extracellular loop of the channel plays a role in regulation of ATP potency, however, whether this results from an effect on agonist binding and/or gating remains to be determined. What is clear is that residues involved in agonist action at P2X receptors are not just focused around regions close to the transmembrane segments and the pore of the channel.
###end p 56
###begin p 57
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 483 488 483 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,2,4</sub>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 537 538 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 609 616 609 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 642 643 642 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 786 787 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1111 1112 1099 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1120 1121 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1297 1298 1285 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1345 1348 1333 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
###xml 1492 1494 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1496 1498 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1692 1696 1680 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
At the conserved NFR motif cysteine substitution at Asn and Arg reduced ATP potency by >300-fold and gave marked reductions in peak current amplitudes (>80%) at P2X2 and P2X4 receptors. The asparagine to cysteine mutation had the same effect at P2X2 (N288C) and P2X4 (N293C) receptors with inhibition of currents by either MTS reagent as reported previously for P2X1 receptors (16). The reduction of ATP responses at the mutants of the conserved arginine by MTSES is the same for P2X1,2,4 receptors, however, MTSEA inhibited P2X1 and P2X4 receptors, but potentiated the P2X2 receptor (Ref. 16 and this study, Table 2). This shows that the P2X1 and P2X4 receptors are similar in that the MTS reagents interfere with the action of ATP in a way that is charge independent. However, for P2X2 the results are consistent with the polarity of charge at this position being important. When the phenylalanine of the NFR motif was replaced with cysteine there was only a modest approximately4-fold reduction in ATP potency, no effect on peak current amplitude, and MTS reagents were ineffective. This suggests that at P2X2 and P2X4 receptors the conservation of the asparagine and arginine residues is more important in regulating the actions of ATP than the phenylalanine of which they are adjacent. At P2X1 receptors and a non-desensitizing chimeric P2X1/2 receptor, marked effects of >100-fold decrease in ATP potency with no effect on the peak response were recorded with the equivalent mutations (16, 18). Taken together these results show that whereas there are marked similarities between the receptors, there are also differences in regulation of ATP potency between the P2X receptor subunits (e.g. the effects of MTSEA on cysteine substitution of the arginine of the NFR motif). This is consistent with variations in the pharmacological properties of P2X receptors and suggests that non-conserved amino acids are associated with agonist action.
###end p 57
###begin p 58
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 87 7 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants</bold>
###xml 7 87 7 87 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="59"><bold>Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants</bold></p>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 87 354 87 354 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="60">Arrows correspond to significant effects of MTS reagents on ATP responses. Shaded areas correspond to similar effects of the MTS reagents at different P2X receptor subtype mutants. Data for the P2X<sub>1</sub> receptor from (<xref ref-type="bibr" rid="ref16">16</xref>). ND, not done; NE, no effect could be determined.</p>
###xml 7 354 7 354 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="59"><bold>Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants</bold></p><p textid="60">Arrows correspond to significant effects of MTS reagents on ATP responses. Shaded areas correspond to similar effects of the MTS reagents at different P2X receptor subtype mutants. Data for the P2X<sub>1</sub> receptor from (<xref ref-type="bibr" rid="ref16">16</xref>). ND, not done; NE, no effect could be determined.</p></caption>
###xml 354 354 354 354 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc032084380t002"/>
###xml 0 354 0 354 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="59"><bold>Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants</bold></p><p textid="60">Arrows correspond to significant effects of MTS reagents on ATP responses. Shaded areas correspond to similar effects of the MTS reagents at different P2X receptor subtype mutants. Data for the P2X<sub>1</sub> receptor from (<xref ref-type="bibr" rid="ref16">16</xref>). ND, not done; NE, no effect could be determined.</p></caption><graphic xlink:href="zbc032084380t002"/></table-wrap>
TABLE 2Summary of data for the effects of MTS reagents at P2X receptor cysteine mutantsArrows correspond to significant effects of MTS reagents on ATP responses. Shaded areas correspond to similar effects of the MTS reagents at different P2X receptor subtype mutants. Data for the P2X1 receptor from (16). ND, not done; NE, no effect could be determined.
###end p 58
###begin p 59
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants</bold>
Summary of data for the effects of MTS reagents at P2X receptor cysteine mutants
###end p 59
###begin p 60
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
Arrows correspond to significant effects of MTS reagents on ATP responses. Shaded areas correspond to similar effects of the MTS reagents at different P2X receptor subtype mutants. Data for the P2X1 receptor from (16). ND, not done; NE, no effect could be determined.
###end p 60
###begin p 61
###xml 102 103 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">292</sup>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">290</sup>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">291</sup>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 545 546 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 774 775 774 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 859 860 859 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1169 1170 1169 1170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1178 1179 1178 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1502 1503 1502 1503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1511 1512 1511 1512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
The present study shows that the NFR region plays an important role in regulation of ATP action at P2X2 and P2X4 receptors. We have previously shown, for P2X1 receptors, that reductions in ATP potency at cysteine mutants of the NFR motif are likely to result from effects on agonist binding at Arg292 and effects on both binding and gating for Asn290 and Phe291 (16). The contribution of this region to the agonist binding site is supported by a recent paper (18) showing that the phenylalanine is close to the conserved Lys68 residue in the P2X1 receptor and cysteine mutants K68C and F291C can form an inter-subunit disulfide bond and this is inhibited by ATP, suggesting that both residues are close to the ATP binding site. Similarly a recent single channel study on P2X2 receptors reported that the reduction of ATP potency for the K69A mutant of the P2X2 receptor results predominantly from an effect on agonist binding (32). So how may the NFR region be involved in coordination of ATP binding? Previously we had suggested that the phenylalanine residues in the NFR motif were involved in binding of the adenine ring of ATP. However, the present results from P2X2 and P2X4 receptors with modest changes in ATP for cysteine mutants of these phenylalanines and the lack of effect of MTS reagents on ATP responses suggests that the conserved aromatic residue may not contribute directly to agonist recognition. The inhibition of cysteine-substituted mutants of the arginine of the NFR motif for P2X1 and P2X4 receptors by both positive and negatively charged MTS reagents suggests that arginine is not directly involved in binding of the phosphate tail of ATP. This suggests that asparagine and arginine are most likely involved in binding of the ribose and/or adenine ring of ATP.
###end p 61
###begin p 62
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 56 9 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of the ATP binding site at P2X receptors.</bold>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 261 271 261 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray arrow</italic>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 715 716 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 742 744 742 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">69</sup>
###xml 749 751 749 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">71</sup>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">313</sup>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">313</sup>
###xml 1023 1024 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1078 1089 1078 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dotted line</italic>
###xml 9 1306 9 1306 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="63"><bold>Model of the ATP binding site at P2X receptors.</bold> Portions of the extracellular loop adjacent to either the first (in <italic>gray</italic>) or second (in <italic>black</italic>) transmembrane domain are shown for two adjacent P2X receptor subunits (numbering for the P2X<sub>4</sub> receptor). The <italic>gray arrow</italic> represents the disulfide bond that can be formed between cysteine mutations of these residues at the P2X<sub>1</sub> receptor (<xref ref-type="bibr" rid="ref18">18</xref>). Residues that showed a decrease in ATP potency when mutated to cysteine are shown, those in <italic>black</italic> correspond to those that were modified by MTS reagents, whereas those in <italic>gray</italic> were unaffected by either MTSEA or MTSES. Positively charged MTSEA increased the amplitude and potency of responses at cysteine mutants of the P2X<sub>4</sub> receptor at positions Lys<sup>69</sup>, Lys<sup>71</sup> and Lys<sup>313</sup>, this suggests a role of these residues in coordinating the binding of the negatively charged phosphate of ATP, however, it is possible that they also contribute to the gating of the channel as has been suggested for the residue equivalent to Lys<sup>313</sup> at the P2X<sub>2</sub> receptor (<xref ref-type="bibr" rid="ref32">32</xref>). The conserved FT region is shown as a <italic>dotted line</italic> as it has been shown to be involved in agonist potency and is unclear whether the effects result from changes in agonist binding and/or gating. One possibility is that threonine could face the agonist binding pocket.</p>
###xml 9 1306 9 1306 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="63"><bold>Model of the ATP binding site at P2X receptors.</bold> Portions of the extracellular loop adjacent to either the first (in <italic>gray</italic>) or second (in <italic>black</italic>) transmembrane domain are shown for two adjacent P2X receptor subunits (numbering for the P2X<sub>4</sub> receptor). The <italic>gray arrow</italic> represents the disulfide bond that can be formed between cysteine mutations of these residues at the P2X<sub>1</sub> receptor (<xref ref-type="bibr" rid="ref18">18</xref>). Residues that showed a decrease in ATP potency when mutated to cysteine are shown, those in <italic>black</italic> correspond to those that were modified by MTS reagents, whereas those in <italic>gray</italic> were unaffected by either MTSEA or MTSES. Positively charged MTSEA increased the amplitude and potency of responses at cysteine mutants of the P2X<sub>4</sub> receptor at positions Lys<sup>69</sup>, Lys<sup>71</sup> and Lys<sup>313</sup>, this suggests a role of these residues in coordinating the binding of the negatively charged phosphate of ATP, however, it is possible that they also contribute to the gating of the channel as has been suggested for the residue equivalent to Lys<sup>313</sup> at the P2X<sub>2</sub> receptor (<xref ref-type="bibr" rid="ref32">32</xref>). The conserved FT region is shown as a <italic>dotted line</italic> as it has been shown to be involved in agonist potency and is unclear whether the effects result from changes in agonist binding and/or gating. One possibility is that threonine could face the agonist binding pocket.</p></caption>
###xml 1306 1306 1306 1306 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0320843800008"/>
###xml 0 1306 0 1306 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="63"><bold>Model of the ATP binding site at P2X receptors.</bold> Portions of the extracellular loop adjacent to either the first (in <italic>gray</italic>) or second (in <italic>black</italic>) transmembrane domain are shown for two adjacent P2X receptor subunits (numbering for the P2X<sub>4</sub> receptor). The <italic>gray arrow</italic> represents the disulfide bond that can be formed between cysteine mutations of these residues at the P2X<sub>1</sub> receptor (<xref ref-type="bibr" rid="ref18">18</xref>). Residues that showed a decrease in ATP potency when mutated to cysteine are shown, those in <italic>black</italic> correspond to those that were modified by MTS reagents, whereas those in <italic>gray</italic> were unaffected by either MTSEA or MTSES. Positively charged MTSEA increased the amplitude and potency of responses at cysteine mutants of the P2X<sub>4</sub> receptor at positions Lys<sup>69</sup>, Lys<sup>71</sup> and Lys<sup>313</sup>, this suggests a role of these residues in coordinating the binding of the negatively charged phosphate of ATP, however, it is possible that they also contribute to the gating of the channel as has been suggested for the residue equivalent to Lys<sup>313</sup> at the P2X<sub>2</sub> receptor (<xref ref-type="bibr" rid="ref32">32</xref>). The conserved FT region is shown as a <italic>dotted line</italic> as it has been shown to be involved in agonist potency and is unclear whether the effects result from changes in agonist binding and/or gating. One possibility is that threonine could face the agonist binding pocket.</p></caption><graphic xlink:href="zbc0320843800008"/></fig>
FIGURE 8.Model of the ATP binding site at P2X receptors. Portions of the extracellular loop adjacent to either the first (in gray) or second (in black) transmembrane domain are shown for two adjacent P2X receptor subunits (numbering for the P2X4 receptor). The gray arrow represents the disulfide bond that can be formed between cysteine mutations of these residues at the P2X1 receptor (18). Residues that showed a decrease in ATP potency when mutated to cysteine are shown, those in black correspond to those that were modified by MTS reagents, whereas those in gray were unaffected by either MTSEA or MTSES. Positively charged MTSEA increased the amplitude and potency of responses at cysteine mutants of the P2X4 receptor at positions Lys69, Lys71 and Lys313, this suggests a role of these residues in coordinating the binding of the negatively charged phosphate of ATP, however, it is possible that they also contribute to the gating of the channel as has been suggested for the residue equivalent to Lys313 at the P2X2 receptor (32). The conserved FT region is shown as a dotted line as it has been shown to be involved in agonist potency and is unclear whether the effects result from changes in agonist binding and/or gating. One possibility is that threonine could face the agonist binding pocket.
###end p 62
###begin p 63
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of the ATP binding site at P2X receptors.</bold>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 252 262 252 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray arrow</italic>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 706 707 706 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 733 735 733 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">69</sup>
###xml 740 742 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">71</sup>
###xml 750 753 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">313</sup>
###xml 1000 1003 1000 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">313</sup>
###xml 1014 1015 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1069 1080 1069 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dotted line</italic>
Model of the ATP binding site at P2X receptors. Portions of the extracellular loop adjacent to either the first (in gray) or second (in black) transmembrane domain are shown for two adjacent P2X receptor subunits (numbering for the P2X4 receptor). The gray arrow represents the disulfide bond that can be formed between cysteine mutations of these residues at the P2X1 receptor (18). Residues that showed a decrease in ATP potency when mutated to cysteine are shown, those in black correspond to those that were modified by MTS reagents, whereas those in gray were unaffected by either MTSEA or MTSES. Positively charged MTSEA increased the amplitude and potency of responses at cysteine mutants of the P2X4 receptor at positions Lys69, Lys71 and Lys313, this suggests a role of these residues in coordinating the binding of the negatively charged phosphate of ATP, however, it is possible that they also contribute to the gating of the channel as has been suggested for the residue equivalent to Lys313 at the P2X2 receptor (32). The conserved FT region is shown as a dotted line as it has been shown to be involved in agonist potency and is unclear whether the effects result from changes in agonist binding and/or gating. One possibility is that threonine could face the agonist binding pocket.
###end p 63
###begin p 64
###xml 258 264 258 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
In summary our results support the idea that mammalian P2X receptors share a common agonist binding site with the negative charge of ATP coordinated by positively charged lysine residues and the NFR motif involved in binding of the adenine/ribose component (Fig. 8). The conserved FT motif also contributes to agonist action, however, whether this results from an effect on agonist binding and/or gating remains to be determined.
###end p 64
###begin p 65
The abbreviations used are: MTS, methanethiosulfonate; MTSEA, (2-aminoethyl)methanethiosulfonate hydrobromide; MTSES, sodium (2-sulfonatoethyl)methanethiosulfonate; WT, wild type.
###end p 65
###begin p 66
R. A. McMahon, T. M. Egan, P. T. Hurley, A. Nelson, M. Rogers, and F. Martin, submitted to EMBL-EBI Data Bank with accession number AF109387.
###end p 66

